Newtopia Inc.

Equities

NEWU

CA6532261006

Healthcare Facilities & Services

Delayed Toronto S.E. Other stock markets 03:21:30 2024-05-07 pm EDT			5-day change	1st Jan Change
0.065 ^CAD	+62.50%		0.00%	-23.53%

Feb. 29	Newtopia Up Over 27% After Reporting $746,500 Offering	MT
Feb. 29	Newtopia Inc. announced that it has received CAD 0.7465 million in funding	CI

Newtopia Inc. Provides Revenue Guidance for the Year 2022

November 08, 2022 at 04:30 pm EST

Newtopia Inc. provided revenue guidance for the year 2022. Given the year-to-date performance, the Company continues to anticipate achieving full year revenue growth for 2022 over full year 2021. With an expanded business development effort and the geographic expansion with a current Fortune 50 client, revenue is expected to benefit in the final quarter of the year.

In the fourth quarter, the Company will continue to work towards onboarding a new set of health plan clients in addition to driving organic growth with its current set of self-insured employer clients to position Newtopia for further revenue improvements in 2023.

Latest news about Newtopia Inc.

Newtopia Up Over 27% After Reporting $746,500 Offering	Feb. 29	MT
Newtopia Inc. announced that it has received CAD 0.7465 million in funding	Feb. 28	CI
Newtopia Launches "Glp-1 Sustain" Program to Affordably Preserve and Extend Valuable Health Benefits of Novel Weight Loss Drugs	Jan. 29	CI
Transcript : Newtopia Inc., Q3 2023 Earnings Call, Nov 16, 2023	Nov. 16
Newtopia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 16	CI
Newtopia Brief: Improves Gross Margin (non IFRS) by 1,100 basis points year-over-year	Nov. 16	MT
Newtopia Brief: Says Achieved EBITDA "Positive" for first full quarter in Company history' Decreases operating expenses by 52% year-over-year	Nov. 16	MT
Newtopia Brief: Q3 Revenue of $2.43 million, as compared to $2.65 million	Nov. 16	MT
Newtopia Inc. announced that it has received CAD 0.805 million in funding	23-10-15	CI
Newtopia Completed Prior Announced Debenture Extension	23-09-18	MT
Newtopia to Amend Convertible Debentures, Proposes Non-Brokered Offering of Subordinated Non-Convertible Debentures	23-09-12	MT
Newtopia Inc. announced that it expects to receive CAD 2.545 million in funding	23-09-10	CI
Newtopia Higher After Announcing Exercise of Warrants	23-09-08	MT
Transcript : Newtopia Inc., Q2 2023 Earnings Call, Aug 09, 2023	23-08-09
Newtopia Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Newtopia Inc. Provides Earnings Guidance for the Year 2023	23-08-09	CI
Newtopia Inc. announced that it has received CAD 1.5 million in funding	23-07-13	CI
Newtopia Brief: Says Expects to use the proceeds of the Offering for corporate and general working capital purposes	23-06-27	MT
Newtopia Brief: Announcing a proposed non-brokered offering of subordinated and postponed 13% secured non-convertible debenture units pursuant to which Newtopia proposes to raise gross proceeds of up to $500,000	23-06-27	MT
Newtopia Inc. announced that it expects to receive CAD 0.5 million in funding	23-06-26	CI
Newtopia Inc. Renews Multi-Year Partnership with Fortune-500 Healthcare Juggernaut to Prevent, Slow and Reverse Chronic Disease Through Sustainable Habit Change	23-06-19	CI
Newtopia Brief: As a result of Share Purchase, McCauley Owns and Controls Near 13,994,500 Shares and 1 Million Common Share Purchase Warrants, Representing 10% of Shares On a Partially Diluted Basis	23-06-02	MT
Newtopia Brief: Hugh G. McCauley Says Acquired 100,000 Common Shares For a Purchase Price of $0.075 per Share	23-06-02	MT
Newtopia Inc. announced that it has received CAD 0.0075 million in funding	23-05-31	CI
Newtopia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI

Chart Newtopia Inc.

Duration

Period

More charts

Company Profile

Newtopia Inc. is a Canada-based technology-enabled habit change company that delivers disease prevention solutions by leveraging genetic testing, social and behavioral science to help individuals prevent chronic disease and reduce costs for health insurers. As a provider of whole-person care, it prevents, reverses and slows the progression of chronic disease while enriching mental health, resilience and overall human performance. The Companyâs programs leverage genetic, social, and behavioral insights to create individualized prevention programs with a focus on type two diabetes, heart disease, stroke, metabolic disease, mental health challenges, hypertension, weight management and musculoskeletal disorders. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, the Company delivers sustainable clinical and financial outcomes. Its personalized habit change platform focuses on physical and mental health risk reduction.

Sector

Healthcare Facilities & Services

Calendar

2024-08-06 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
NEWTOPIA INC.	-23.53%	8.25M
HCA HEALTHCARE, INC.	+18.22%	84.11B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.04%	27.25B
LABCORP HOLDINGS INC.	-10.27%	17.31B
FRESENIUS SE & CO. KGAA	-1.57%	16.83B
QUEST DIAGNOSTICS INCORPORATED	+3.48%	15.92B
REDE D'OR SÃO LUIZ S.A.	+1.67%	13.68B
NATERA, INC.	+72.52%	13.29B
TENET HEALTHCARE CORPORATION	+72.96%	12.73B
FRESENIUS MEDICAL CARE AG	+2.08%	12.62B

Other Healthcare Facilities & Services